NCT01394913View on ClinicalTrials.gov

Comparison of Two Etanercept Regimens (REUMATOCEPT® Versus ENBREL®) for Treatment of Rheumatoid Arthritis

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

August 31, 2013

Primary Completion Date

March 31, 2014

Study Completion Date

June 30, 2014

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Reumatocept (etanercept)

50mg each week for 30 weeks

DRUG

Enbrel (etanercept)

50mg each week for 30 weeks

Trial Locations (1)

04038004

Associação de Assitência à Criança Deficiente, São Paulo

Sponsors

Lead Sponsor

EMS
All Listed Sponsors
lead

EMS

INDUSTRY

NCT01394913 - Comparison of Two Etanercept Regimens (REUMATOCEPT® Versus ENBREL®) for Treatment of Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter